BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29654610)

  • 1. Urinary fibrin/fibrinogen degradation products measured using an anti-fibrinogen antibody predict orthostatic proteinuria.
    Kanai H; Sawanobori E; Kobayashi A; Goto M; Higashida K; Sugita K
    Pediatr Int; 2018 Jul; 60(7):639-644. PubMed ID: 29654610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children.
    Brandt JR; Jacobs A; Raissy HH; Kelly FM; Staples AO; Kaufman E; Wong CS
    Pediatr Nephrol; 2010 Jun; 25(6):1131-7. PubMed ID: 20165888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
    Hall CL; Pejhan N; Terry JM; Blainey JD
    Br Med J; 1975 Feb; 1(5955):419-22. PubMed ID: 803853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficacy and influence factors of urinary protein/creatinine ratio replacing 24-h urine protein as an evaluator of proteinuria in children.
    Zhai P; Huang Y; Yue S; Yang X; Luo J; Zhang Y; Mei X; Bi L; Zhai W; Ren X; Yang Y; Zheng X; Yamamoto T
    Int Urol Nephrol; 2022 Jun; 54(6):1409-1416. PubMed ID: 34668110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of urine protein/creatinine ratios to 24-h urinary protein for quantitating proteinuria in children.
    Huang Y; Yang X; Zhang Y; Yue S; Mei X; Bi L; Zhai W; Ren X; Ding Y; Zhang S; Deng Z; Sun Y
    Pediatr Nephrol; 2020 Mar; 35(3):463-468. PubMed ID: 31813022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on urinary protein components in renal disease in children, II--Comparison between children with orthostatic albuminuria and children with remission of glomerulonephritis].
    Ohshima T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1137-44. PubMed ID: 7815746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of supine/standing urinalysis for differential diagnosis of left renal vein entrapment syndrome combined with or without glomerulopathy.
    Jin M; Hu P; Ding R; Chen P; Qiu Q; Wu J; Liu S; Xie Y; Chen X
    Nephrology (Carlton); 2014 Jun; 19(6):332-8. PubMed ID: 24629105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of urinary fibrin degradation products.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Nephron; 1980; 25(1):25-9. PubMed ID: 6986037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
    Clarkson AR; MacDonald MK; Petrie JJ; Cash JD; Robson JS
    Br Med J; 1971 Aug; 3(5772):447-51. PubMed ID: 5567767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].
    Lagrue G; Hirbec G; Gouault-Heilmann M; Levent M; Branellec A; Moisy M
    Pathol Biol (Paris); 1975 Jun; 23(6):486-91. PubMed ID: 1105353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
    Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary crosslinked fibrin degradation products in glomerular disease.
    Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
    Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?
    Morales JV; Weber R; Wagner MB; Barros EJ
    J Nephrol; 2004; 17(5):666-72. PubMed ID: 15593033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum myeloid-related protein 8/14 in minimal change- and glomerulonephritis-related nephrotic syndrome.
    Ohara S; Kawasaki Y; Maeda R; Kanno S; Suzuki Y; Suyama K; Hosoya M
    Pediatr Int; 2016 Oct; 58(10):998-1002. PubMed ID: 26891373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does measurement of urinary rare proteins provide diagnostic significance in glomerular diseases?
    Nagase M; Sakakibara K; Honda N; Takada Y; Takada A
    Contrib Nephrol; 1988; 68():141-8. PubMed ID: 3069315
    [No Abstract]   [Full Text] [Related]  

  • 19. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E; Worawichawong S; Radinahamed P; Sathirapongsasuti N; Nongnuch A; Assanatham M; Udomsubpayakul U; Kitiyakara C
    Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells.
    Hamadah AM; Gharaibeh K; Mara KC; Thompson KA; Lieske JC; Said S; Nasr SH; Leung N
    Nephrol Dial Transplant; 2018 Aug; 33(8):1397-1403. PubMed ID: 29156008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.